Search

Your search keyword '"Akio Kihara"' showing total 76 results

Search Constraints

Start Over You searched for: Author "Akio Kihara" Remove constraint Author: "Akio Kihara" Topic humans Remove constraint Topic: humans
76 results on '"Akio Kihara"'

Search Results

1. Amlexanox enhances the antitumor effect of anti-PD-1 antibody

2. Ceramide profiling of stratum corneum in Sjögren-Larsson syndrome

3. Impaired production of skin barrier lipid acylceramides and abnormal localization of PNPLA1 due to ichthyosis-causing mutations in PNPLA1

4. Comprehensive stratum corneum ceramide profiling reveals reduced acylceramides in ichthyosis patient with CERS3 mutations

5. Comparative profiling and comprehensive quantification of stratum corneum ceramides in humans and mice by LC/MS/MS[S]

6. Hypomyelinating spastic dyskinesia and ichthyosis caused by a homozygous splice site mutation leading to exon skipping in ELOVL1

7. Impaired production of the skin barrier lipid acylceramide by CYP4F22 ichthyosis mutations

8. Whole picture of human stratum corneum ceramides, including the chain-length diversity of long-chain bases

9. Widespread tissue distribution and synthetic pathway of polyunsaturated C24:2 sphingolipids in mammals

10. Molecular mechanism of the ichthyosis pathology of Chanarin–Dorfman syndrome: Stimulation of PNPLA1-catalyzed ω-O-acylceramide production by ABHD5

11. Production of branched-chain very-long-chain fatty acids by fatty acid elongases and their tissue distribution in mammals

12. Skin permeability barrier formation by the ichthyosis-causative gene FATP4 through formation of the barrier lipid ω-O-acylceramide

13. Neural symptoms in a gene knockout mouse model of Sjögren‐Larsson syndrome are associated with a decrease in 2‐hydroxygalactosylceramide

14. The 3-hydroxyacyl-CoA dehydratases HACD1 and HACD2 exhibit functional redundancy and are active in a wide range of fatty acid elongation pathways

15. PNPLA1 is a transacylase essential for the generation of the skin barrier lipid ω-O-acylceramide

16. Biallelic Mutations in KDSR Disrupt Ceramide Synthesis and Result in a Spectrum of Keratinization Disorders Associated with Thrombocytopenia

17. Severe Skin Permeability Barrier Dysfunction in Knockout Mice Deficient in a Fatty Acid ω-Hydroxylase Crucial to Acylceramide Production

18. The very-long-chain fatty acid elongase Elo2 rescues lethal defects associated with loss of the nuclear barrier function in fission yeast cells

19. Structure-inspired design of a sphingolipid mimic sphingosine-1-phosphate receptor agonist from a naturally occurring sphingomyelin synthase inhibitor

20. Direct uptake of sphingosine-1-phosphate independent of phospholipid phosphatases

21. Enzyme Activities of the Ceramide Synthases CERS2-6 Are Regulated by Phosphorylation in the C-terminal Region

22. A role of the sphingosine-1-phosphate (S1P)–S1P receptor 2 pathway in epithelial defense against cancer (EDAC)

23. The role of PNPLA1 in ω-O-acylceramide synthesis and skin barrier function

24. Sphingosine 1-phosphate receptor modulator ONO-4641 stimulates CD11b

25. Mouse aldehyde dehydrogenase ALDH3B2 is localized to lipid droplets via two C-terminal tryptophan residues and lipid modification

26. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

27. Phytosphingosine degradation pathway includes fatty acid α-oxidation reactions in the endoplasmic reticulum

28. Sphingosine 1-phosphate is a key metabolite linking sphingolipids to glycerophospholipids

29. Lorenzo's oil inhibits ELOVL1 and lowers the level of sphingomyelin with a saturated very long-chain fatty acid

30. Identification of acyl-CoA synthetases involved in the mammalian sphingosine 1-phosphate metabolic pathway

31. Mutation for Nonsyndromic Mental Retardation in the trans-2-Enoyl-CoA Reductase TER Gene Involved in Fatty Acid Elongation Impairs the Enzyme Activity and Stability, Leading to Change in Sphingolipid Profile

32. Congenital myopathy is caused by mutation of HACD1

33. Substrate specificity, plasma membrane localization, and lipid modification of the aldehyde dehydrogenase ALDH3B1

34. Mechanistic Details of Early Steps in Coenzyme Q Biosynthesis Pathway in Yeast

35. Synthesis and degradation pathways, functions, and pathology of ceramides and epidermal acylceramides

36. A shift in sphingolipid composition from C24 to C16 increases susceptibility to apoptosis in HeLa cells

37. The Sjögren-Larsson Syndrome Gene Encodes a Hexadecenal Dehydrogenase of the Sphingosine 1-Phosphate Degradation Pathway

38. Analysis of substrate specificity of human DHHC protein acyltransferases using a yeast expression system

39. HACD1, a regulator of membrane composition and fluidity, promotes myoblast fusion and skeletal muscle growth

40. Biochemical characterization of the very long-chain fatty acid elongase ELOVL7

41. ELOVL1 production of C24 acyl-CoAs is linked to C24 sphingolipid synthesis

42. Ceramide biosynthesis in keratinocyte and its role in skin function

43. 2-Hydroxy-ceramide synthesis by ceramide synthase family: enzymatic basis for the preference of FA chain length

44. A splicing isoform of LPP1, LPP1a, exhibits high phosphatase activity toward FTY720 phosphate

45. Production and release of sphingosine 1-phosphate and the phosphorylated form of the immunomodulator FTY720

46. Rapid trafficking of c-Src, a non-palmitoylated Src-family kinase, between the plasma membrane and late endosomes/lysosomes

47. Lack of sphingosine 1-phosphate-degrading enzymes in erythrocytes

48. Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate

49. Essential role of the cytochrome P450 CYP4F22 in the production of acylceramide, the key lipid for skin permeability barrier formation

50. Histological analyses by matrix-assisted laser desorption/ionization-imaging mass spectrometry reveal differential localization of sphingomyelin molecular species regulated by particular ceramide synthase in mouse brains

Catalog

Books, media, physical & digital resources